Indaptus Therapeutics is trading 10.61% up at $2.35 amid a broad market rally, though no direct cause for its move has been confirmed. - No verified company-specific announcement explaining the gain was found. - On October 2, 2026, September payrolls rose by 29,000, below expectations, easing rate-hike concerns and lifting stocks. - Reuters reported U.S. indexes opened higher after the jobs data.